Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Use this INO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INO SEC filings page. Lician reads the product cache first so this HTML stays unique to Inovio Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full INO income, balance, and cash tables.